Published in Immunotherapy Weekly, February 11th, 2009
"The augmentation of capsaicin-evoked SP release by GR73632 was completely inhibited by pharmacological...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Immunotherapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.